APA (7th ed.) Citation

M, S., C, S., A, S., C, S., E, K., R, S., . . . M, G. (2023). Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy. Journal of virus eradication, 9(1), 100319. https://doi.org/10.1016/j.jve.2023.100319

Chicago Style (17th ed.) Citation

M, Schwarz, et al. "Combining Treatment for Chronic Hepatitis C with Opioid Agonist Therapy Is an Effective Microelimination Strategy for People Who Inject Drugs with High Risk of Non-adherence to Direct-acting Antiviral Therapy." Journal of Virus Eradication 9, no. 1 (2023): 100319. https://doi.org/10.1016/j.jve.2023.100319.

MLA (9th ed.) Citation

M, Schwarz, et al. "Combining Treatment for Chronic Hepatitis C with Opioid Agonist Therapy Is an Effective Microelimination Strategy for People Who Inject Drugs with High Risk of Non-adherence to Direct-acting Antiviral Therapy." Journal of Virus Eradication, vol. 9, no. 1, 2023, p. 100319, https://doi.org/10.1016/j.jve.2023.100319.